A newly proposed model suggests cancer cells may resist treatment not just through genetic mutations, but by dynamically ...
Dr. Georg Winter explores how chemical neomorphs can give proteins new functions by reshaping their cellular interactions, ...
Cardiovascular diseases (CVDs) remain the leading cause of death worldwide and are now increasingly recognized as conditions with a strong ...
A new grant from the American Cancer Society (ACS) will fund research into a new strategy for targeting glioblastoma at MUSC ...
This important paper substantially advances our understanding of how Molidustat may work, beyond its canonical role, by identifying its therapeutic targets in cancer. This study presents a compelling ...
Brain function has traditionally been interpreted within a neuron-centric framework; however, this view has shifted toward a model of neuron-glia ...
Objective Macrophages and kidney cell pyroptosis/ferroptosis could play an important role in the pathogenesis of lupus ...
A burgeoning field is launching its first clinical trial to find out whether dialing back cell development can safely refresh ...
From billionaire-backed biotech to promising animal studies, this early trial will test whether partial reprogramming can ...
The field of partial reprogramming is transitioning from successful mouse studies to its first human clinical trials. At the heart of this experiment lies the discovery of Yamanaka factors, proteins ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results